Clinical Trial: Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542990) titled 'Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care' on March 05.

Brief Summary: The goal of this clinical trial is to learn if dexmedetomidine can reduce delirium in critically ill children, needing mechanical ventilation for more than 12 hours. The main question it aims to answer is :

* Does dexmedetomidine reduce the proportion of children presenting at least one episode of delirium during their intensive care unit (ICU) stay ? Researchers will compare dexmetomidine to midazolam, to see if the use of dexmedetomidine reduces the prevalence of delirium.

Participants will be sedated...